Clincosm LogoSign in Get a demo

Ocular Hypertension

Showing NaN - NaN of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glaucoma, Open-Angle, Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Sham Bimatoprost SR, Selective Laser

Active, not recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Bimatoprost SR
  • +3 more
  • Dothan, Alabama
  • +94 more
Nov 1, 2022

Open-Angle Glaucoma, Ocular Hypertension Trial in Worldwide (Bimatoprost (SR))

Recruiting
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Bimatoprost (SR)
  • Sun City, Arizona
  • +112 more
Aug 16, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in United States (Brimonidine Tartrate Ophthalmic Suspension, Brimonidine

Completed
Has Results
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Brimonidine Tartrate Ophthalmic Suspension
  • Brimonidine Tartrate Ophthalmic Solution
  • Chandler, Arizona
  • +46 more
Jan 27, 2022

Primary Open Angle Glaucoma, Ocular Hypertension Trial in United States (DE-126 Ophthalmic Solution 0.002% QD, Timolol Maleate

Completed
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • DE-126 Ophthalmic Solution 0.002% QD
  • Timolol Maleate Ophthalmic Solution 0.5% BID
  • Chandler, Arizona
  • +40 more
Feb 10, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in United States (Xalacom, Xalatan, Timolol)

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Birmingham, Alabama
  • +63 more
Feb 17, 2021

Glaucoma, Ocular Hypertension Trial in United States (RKI983A, Latanoprost)

Completed
  • Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +28 more
Dec 11, 2020

Glaucoma, Open-Angle, Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Active Comparator: Timolol 0.5%, Sham: Applicator

Completed
Has Results
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Bimatoprost SR
  • +3 more
  • Phoenix, Arizona
  • +105 more
May 29, 2020

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Ocular Insert)

Completed
Has Results
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Fayetteville, Arkansas
  • +9 more
May 18, 2020

Open-Angle Glaucoma, Ocular Hypertension Trial in Worldwide (bimatoprost 20 µg generation 2, bimatoprost 15 µg generation 2,

Completed
Has Results
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • bimatoprost 20 µg generation 2
  • +6 more
  • Artesia, California
  • +56 more
Mar 27, 2020

Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG324 Ophthalmic Solution 0.01%, PG324 Ophthalmic Solution

Completed
Has Results
  • Open Angle Glaucoma
  • Ocular Hypertension
  • PG324 Ophthalmic Solution 0.01%
  • +3 more
  • Artesia, California
  • +22 more
May 14, 2019

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)

Completed
Has Results
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Fayetteville, Arkansas
  • +8 more
Mar 26, 2019

Open-angle Glaucoma, Ocular Hypertension Trial in United States (DE-117 Low Dose ophthalmic solution, DE-117 Low/Middle Dose

Completed
  • Open-angle Glaucoma
  • Ocular Hypertension
  • DE-117 Low Dose ophthalmic solution
  • +5 more
  • Chandler, Arizona
  • +13 more
Apr 16, 2018

Ocular Hypertension, Open Angle Glaucoma Trial in United States (AR-13324 Ophthalmic Solution 0.01%, AR-13324 Ophthalmic

Completed
Has Results
  • Ocular Hypertension
  • Open Angle Glaucoma
  • AR-13324 Ophthalmic Solution 0.01%
  • +3 more
  • Newport Beach, California
  • +10 more
Mar 19, 2018

Ocular Hypertension, Open Angle Glaucoma Trial in United States (AR-13324 Ophthalmic Solution 0.01%, AR-13324 Ophthalmic

Completed
Has Results
  • Ocular Hypertension
  • Open Angle Glaucoma
  • AR-13324 Ophthalmic Solution 0.01%
  • +2 more
  • Artesia, California
  • +21 more
Mar 19, 2018

Primary Open-angle Glaucoma, Ocular Hypertension Trial in United States (LX7101 (0.125%), LX7101 (0.25%), LX7101 Vehicle)

Completed
  • Primary Open-angle Glaucoma
  • Ocular Hypertension
  • LX7101 (0.125%)
  • +2 more
  • Morrow, Georgia
  • +4 more
Aug 31, 2015

Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG286 Ophthalmic Solution 0.5%, AR-12286 Ophthalmic Solution

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • PG286 Ophthalmic Solution 0.5%
  • +2 more
  • Artesia, California
  • +20 more
Feb 17, 2014

Primary Open-angle Glaucoma, Ocular Hypertension Trial in United States (OPA-6566, Placebo, Latanoprost)

Completed
  • Primary Open-angle Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +8 more
Feb 7, 2014

Open-angle Glaucoma, Ocular Hypertension Trial in Austin, San Antonio (DE-112, DE-112 Vehicle Solution, Timolol Maleate

Completed
  • Open-angle Glaucoma
  • Ocular Hypertension
  • Austin, Texas
  • +1 more
Dec 14, 2012

Primary Open Angle Glaucoma, Ocular Hypertension Trial in United States (Stage 1 - ATS907 - Dose 1, Stage 1 - ATS907 - Dose 2,

Unknown status
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • Stage 1 - ATS907 - Dose 1
  • +7 more
  • Artesia, California
  • +4 more
Oct 30, 2012

Open-Angle Glaucoma, Ocular Hypertension Trial in United States (DE-104 ophthalmic solution, low concentration, DE-104

Completed
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • DE-104 ophthalmic solution, low concentration
  • +4 more
  • Artesia, California
  • +13 more
Nov 1, 2011

Open-Angle Glaucoma, Ocular Hypertension Trial in San Antonio (AL-37807)

Completed
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • San Antonio, Texas
    San Antonio Site
Apr 21, 2008